The report highlights the trends prevailing in the market, along with market drivers and deterrents. Factors driving the market growth are the increasing prevalence of blood disorders and rising incidence of cardiovascular diseases. However, high costs and stringent regulations associated with coagulation analyzers hinder the growth of the market.

Based on product, the global coagulation analyzer market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. In 2021, the clinical laboratory analyzers segment accounted for a higher market share. However, the point-of-care (POC) testing analyzers segment is expected to register a CAGR of 7.2% during the forecast period. The market in the point-of-care (POC) testing analyzers segment is growing rapidly because POC measurement tool can be used inside and outside the hospital as a decision-making and management tool. When time is paramount, POC analyzers provide immediate, actionable results in emergency rooms, coronary care units, surgery, and procedure suites. In addition to outpatient clinics and physicians' offices, these devices can assist with patient management in pharmacies, care centers, and patients' homes. POC coagulation analyzers offer timely results without compromising diagnostic quality control provided by central labs.

The COVID-19 pandemic has adversely affected three main aspects of the global economy—production, supply chain, and firms and financial markets. Japan, China, South Korea, India, and Australia were among the most affected countries due to the high number of COVID-19 cases and the associated deaths. During the peak of the outbreak, medical device manufacturers and suppliers shifted their focus from regular coagulation analyzers to developing and supplying COVID-19 essentials and medical devices used for respiratory issues. Thus, COVID-19 outbreak negatively impacted the coagulation analyzers market.

Abbott Laboratories; Danaher Corp; Siemens Healthcare GmbH; Thermo Fisher Scientific Inc; Sysmex Corporation; Horiba Ltd.; Nihon Kohden Corp; F. Hoffmann-La Roche Ltd; Maccura Biotechnology Co Ltd; Bio Group Medical System SRL; and Shenzhen Mindray Bio-Medical Electronics Co., Ltd are a few prominent players operating in the coagulation analyzer market.

View More at https://www.theinsightpartners.com/reports/coagulation-analyzer-market

Companies are launching new and innovative products and services to sustain their position in the coagulation analyzer market. In July 2020, Sysmex launched automated blood coagulation analyzers “CN-6000” and “CN-3000” in Europe, the Middle East and Africa.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876